Dimension Therapeutics
Gene therapy company focused on developing novel treatments for rare diseases. Our team comprises biotech industry veterans and thought leaders in gene therapy and rare diseases.
Launch date
Market cap
-
Enterprise valuation
€236—355m (Dealroom.co estimates Apr 2015.)
Cambridge Massachusetts (HQ)
Financials
Estimates*
| EUR | 2015 | 2016 |
|---|---|---|
| R&D budget | 24.0m | 34.0m |
Source: Dealroom estimates
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
| N/A | $5.0m | Early VC | |
$30.0m | Series A | ||
| N/A | $24.5m | Growth Equity VC | |
$65.0m | Series B | ||
$152m | Acquisition | ||
| N/A | N/A | IPO | |
| Total Funding | €113m | ||
Related Content
Recent News about Dimension Therapeutics
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.